Open AccessComparative efficacy and safety of immune checkpoint inhibitor-related therapies for advanced melanoma: a Bayesian network analysis
Author(s) -
Xin Li,
Junpeng Wang,
Yun Yao,
Lei Yang,
Zhiqin Li,
Changhong Yu,
Peiyan Zhao,
Yongli Yu,
Liying Wang
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.18906
Subject(s) - ipilimumab , medicine , nivolumab , pembrolizumab , oncology , melanoma , clinical trial , immunotherapy , cancer , cancer research
We aimed to compare and rank the effects of 9 immune checkpoint inhibitor-related therapies for treating advanced melanoma.